Connect
MJA
MJA

Thiazolidinediones and type 2 diabetes: new drugs for an old disease

Trisha M O'Moore-Sullivan and Johannes B Prins
Med J Aust 2002; 177 (7): 396.
Published online: 7 October 2002

Re "Thiazolidinediones and type 2 diabetes: new drugs for an old disease", the New Drugs, Old Drugs article by Trisha M O'Moore-Sullivan and Johannes B Prins in the 15 April issue of the Journal (Med J Aust 2002; 176: 381-386), in which an editing error resulted in the word "tryglyceride" replacing "total cholesterol". Thus, on page 383, the first sentence in the second dot point under the subheading "Both drugs increase HDL and LDL and decrease FFA levels; pioglitazone lowers triglyceride levels", the sentence should read "Rosiglitazone also tends to increase total cholesterol level and studies have reported variable effects on ratios of total cholesterol to high-density lipoprotein (HDL) and of LDL to HDL."

  • Trisha M O'Moore-Sullivan1
  • Johannes B Prins2

  • Department of Diabetes and Endocrinology, Princess Alexandra Hospital, Woolloongabba, Brisbane, QLD.


Author

remove_circle_outline Delete Author
add_circle_outline Add Author

Comment
Do you have any competing interests to declare? *

I/we agree to assign copyright to the Medical Journal of Australia and agree to the Conditions of publication *
I/we agree to the Terms of use of the Medical Journal of Australia *
Email me when people comment on this article

Responses are now closed for this article.